0001398344-16-017261.txt : 20160823 0001398344-16-017261.hdr.sgml : 20160823 20160823145946 ACCESSION NUMBER: 0001398344-16-017261 CONFORMED SUBMISSION TYPE: N-PX PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160823 DATE AS OF CHANGE: 20160823 EFFECTIVENESS DATE: 20160823 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMIDEX FUNDS INC CENTRAL INDEX KEY: 0001074440 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-PX SEC ACT: 1940 Act SEC FILE NUMBER: 811-09123 FILM NUMBER: 161847085 BUSINESS ADDRESS: STREET 1: 970 RITTENHOUSE ROAD CITY: EAGLEVILLE STATE: PA ZIP: 19402 BUSINESS PHONE: 888-876-3566 MAIL ADDRESS: STREET 1: 630 FITZWATERTOWN ROAD STREET 2: BUILDING A, 2ND FLOOR CITY: WILLOW GROVE STATE: PA ZIP: 19090-1904 0001074440 S000004489 Amidex35 Israel Mutual Fund C000012356 Amidex35 Israel Mutual Fund Class A AMDAX C000012357 Amidex35 Israel Mutual Fund Class No-Load AMDEX C000012358 Amidex35 Israel Mutual Fund Class C AMDCX N-PX 1 fp0021158_n-px.htm
 
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-09123

AMIDEX Funds, Inc.
Exact name of registrant as specified in charter)
 
970 Rittenhouse Rd
Eagleville, Pa 19403
(Address of principal executive offices)
(Zip code)
   
Matrix 360 Administration, 4520 Main Street, suite 1425
Kansas City, MO 64111
(Name and address of agent for service)
  

Registrant’s telephone number, including area code: 610 666-1330

Date of fiscal year end: 05/31/2017

Date of reporting period: 06/30/2016

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (§§ 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1 -4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.

SEC 2451 (4-03) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
 
AMIDEX35 Israel Mutual Fund
                
Company Name
Symbol
CUSIP
Date
  
 
       
 Matter #
Matter
Proposed By
Vote casted
Vote
Management Vote
         
 
issuer
Yes
For
For
         
 
holder
No
Against
Against
         
 
 
 
Abstain
Abstain
Osem Investment Ltd
OSEM IT
6660624
07/08/15
1
Approval of consolidated financial statements
issuer
Yes
For
For
Osem Investment Ltd
OSEM IT
6660624
07/08/15
2
Re-elect officiating Directors
issuer
Yes
For
For
Osem Investment Ltd
OSEM IT
6660624
07/08/15
3
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Osem Investment Ltd
OSEM IT
6660624
07/08/15
4
Approve terms of Service as Chairman of the Board
issuer
Yes
For
For
Osem Investment Ltd
OSEM IT
6660624
07/08/15
5
Approve compensation of CEO and Chairman
issuer
Yes
Against
For
Osem Investment Ltd
OSEM IT
6660624
07/08/15
6
Approve options to the CEO
issuer
Yes
Against
For
Osem Investment Ltd
OSEM IT
6660624
07/08/15
7
Approve to Grant Indemnity Undertaking to D&O
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
07/09/15
1
Re-elect officiating Directors
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
07/09/15
2
Re-elect external director
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
07/09/15
3
Approve of an ammendment of the articles of incorporation
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
07/09/15
4
Approve compensation policy for officers
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
07/09/15
5
Approve grants to Directors
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
07/09/15
6
Approve grants to Directors
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
07/09/15
7
Approve compensation of CEO and Chairman
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
07/09/15
8
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Israel Corp Ltd/The
ILCO IT
6889678
07/14/15
1
Approve compensation policy for officers
issuer
Yes
Against
For
Israel Corp Ltd/The
ILCO IT
6889678
07/14/15
2
Approve bonus clause in CEO's employment agreement
issuer
Yes
Against
For
Israel Corp Ltd/The
ILCO IT
6889678
07/14/15
3
Approve officers liability insurance policy
issuer
Yes
For
For
Israel Corp Ltd/The
ILCO IT
6889678
07/14/15
4
Approve the remuneration of the Directors
issuer
Yes
For
For
Strauss Group Ltd
STRS
6304115
07/14/15
1
Approval of consolidated financial statements
issuer
Yes
For
For
Strauss Group Ltd
STRS
6304115
07/14/15
2
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Strauss Group Ltd
STRS
6304115
07/14/15
3
Re-elect officiating Directors
issuer
Yes
For
For
Strauss Group Ltd
STRS
6304115
07/14/15
4
Amend provisions of the Article of Association
issuer
Yes
For
For
Strauss Group Ltd
STRS
6304115
07/14/15
5
Amend senior executives compensation policy
issuer
Yes
Against
For
Strauss Group Ltd
STRS
6304115
07/14/15
6
Approve to Grant Indemnity Undertaking to D&O
issuer
Yes
For
For
Strauss Group Ltd
STRS
6304115
07/14/15
7
Approve Purchase of D&O Insurance
issuer
Yes
For
For
Strauss Group Ltd
STRS
6304115
07/14/15
8
Approve to Grant Indemnity Undertaking to D&O
issuer
Yes
For
For
Mizrahi Tefahot Bank Ltd
MZTF IT
6916703
07/15/15
1
Approve the payment to External Directors
issuer
Yes
For
For
First International Bank of Israel
FTIN
6123815
07/16/15
1
Re-elect officiating Directors
issuer
Yes
For
For
First International Bank of Israel
FTIN
6123815
07/16/15
2
Approval of consolidated financial statements
issuer
Yes
For
For
First International Bank of Israel
FTIN
6123815
07/16/15
3
Appoint Auditors and authorize their fees
issuer
Yes
For
For
First International Bank of Israel
FTIN
6123815
07/16/15
4
Appoint Auditors and authorize their fees
issuer
Yes
For
For
First International Bank of Israel
FTIN
6123815
07/16/15
5
Re-elect external director
issuer
Yes
For
For
Bank Hapoalim BM
POLI IT
6075808
02/18/16
1
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Bank Hapoalim BM
POLI IT
6075808
02/18/16
2
Re-elect officiating Directors
issuer
Yes
For
For
Bank Hapoalim BM
POLI IT
6075808
02/18/16
3
Re-elect external director
issuer
Yes
For
For
Bank Hapoalim BM
POLI IT
6075808
02/18/16
4
Approve of an ammendment of the articles of incorporation
issuer
Yes
For
For
Bank Hapoalim BM
POLI IT
6075808
02/18/16
5
Approve of an ammendment of the articles of incorporation
issuer
Yes
For
For
Bank Hapoalim BM
POLI IT
6075808
02/18/16
6
Approve amending compensation policy
issuer
Yes
For
For
Bank Hapoalim BM
POLI IT
6075808
02/18/16
7
Approve exemption agreements
issuer
Yes
For
For
Bank Hapoalim BM
POLI IT
6075808
02/18/16
8
Approval of changes in remuneration of External Directors
issuer
Yes
For
For
Osem Investment Ltd
OSEM IT
6660624
03/17/16
1
Approve transaction with Nestle
issuer
Yes
For
For
Teva Pharmaceutical Industries Ltd
TEVA
881624209
04/18/16
1
Re-elect officiating Directors
issuer
Yes
For
For
Teva Pharmaceutical Industries Ltd
TEVA
881624209
04/18/16
2
Approve compensation policy for officers
issuer
Yes
Against
For
Teva Pharmaceutical Industries Ltd
TEVA
881624209
04/18/16
3
Approve amendment to 2015 Incentive Plan
issuer
Yes
Against
For
Teva Pharmaceutical Industries Ltd
TEVA
881624209
04/18/16
4
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Gazit Globe Ltd
GLOB
6585396
04/20/16
1
Approve of an ammendment of the articles of incorporation
issuer
Yes
For
For
Gazit Globe Ltd
GLOB
6585396
04/20/16
2
Re-elect external director
issuer
Yes
For
For
Perrigo Co
PRGO
714290103
04/26/16
1
Re-elect officiating Directors
issuer
Yes
For
For
Perrigo Co
PRGO
714290103
04/26/16
2
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Perrigo Co
PRGO
714290103
04/26/16
3
Approve compensation policy for officers
issuer
Yes
Against
For
Perrigo Co
PRGO
714290103
04/26/16
4
Approve company shares buyback
issuer
Yes
For
For
Perrigo Co
PRGO
714290103
04/26/16
5
Approve company shares price range
issuer
Yes
For
For
Bezeq Israeli Telecommunication Corp Ltd
BEZQ IT
6098032
05/03/16
1
Approve to amend remuneration policy
issuer
Yes
For
For
Bezeq Israeli Telecommunication Corp Ltd
BEZQ IT
6098032
05/03/16
2
Approve amending company protocols
issuer
Yes
For
For
Bezeq Israeli Telecommunication Corp Ltd
BEZQ IT
6098032
05/03/16
3
Approve to indemnity undertaking to D&O
issuer
Yes
For
For
Bezeq Israeli Telecommunication Corp Ltd
BEZQ IT
6098032
05/03/16
4
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Bezeq Israeli Telecommunication Corp Ltd
BEZQ IT
6098032
05/03/16
5
Approve Distribution of Dividend
issuer
Yes
For
For
Bezeq Israeli Telecommunication Corp Ltd
BEZQ IT
6098032
05/03/16
6
Re-elect officiating Directors
issuer
Yes
For
For
Bezeq Israeli Telecommunication Corp Ltd
BEZQ IT
6098032
05/03/16
7
Approve discussion of the financial statements
issuer
Yes
For
For
Imperva Inc
IMPV
45321L100
05/04/16
1
Re-elect officiating Directors
issuer
Yes
For
For
Imperva Inc
IMPV
45321L100
05/04/16
2
Approve compensation policy for officers
issuer
Yes
Against
For
Imperva Inc
IMPV
45321L100
05/04/16
3
Approve amend 2011 stock option plan
issuer
Yes
Against
For
Imperva Inc
IMPV
45321L100
05/04/16
4
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Ormat Technologies Inc
ORA
686688-102
05/04/16
1
Re-elect officiating Directors
issuer
Yes
For
For
Ormat Technologies Inc
ORA
686688-102
05/04/16
2
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Opko Health Inc
OPK
68375N103
05/05/16
1
Re-elect officiating Directors
issuer
Yes
For
For
Opko Health Inc
OPK
68375N103
05/05/16
2
Approve company incentive plan
issuer
Yes
Against
For
Nice Systems Ltd
NICE
653656-108
05/17/16
1
Re-elect officiating Directors
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
05/17/16
2
Re-elect external director
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
05/17/16
3
Approve of an ammendment of the articles of incorporation
issuer
Yes
For
For
Nice Systems Ltd
NICE
653656-108
05/17/16
4
Approve grants to Directors
issuer
Yes
Against
For
Nice Systems Ltd
NICE
653656-108
05/17/16
5
Approve compensation of CEO and Chairman
issuer
Yes
Against
For
Nice Systems Ltd
NICE
653656-108
05/17/16
6
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Check Point Software Technologies
CHKP
2181334
06/07/16
1
Re-elect officiating Directors
issuer
Yes
For
For
Check Point Software Technologies
CHKP
2181334
06/07/16
2
Appoint Auditors and authorize their fees
issuer
Yes
For
For
Check Point Software Technologies
CHKP
2181334
06/07/16
3
Approve compensation of CEO and Chairman
issuer
Yes
Against
For
Check Point Software Technologies
CHKP
2181334
06/07/16
4
Approve compensation policy for officers
issuer
Yes
Against
For


SIGNATURES
[See General Instruction F]
 Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
(Registrant)
AMIDEX Funds, Inc.  
     
By (Signature and Title)*
/s/ Cliff Goldstein  
     
Date
August 23, 2016  
*
Print the name and title of each signing officer under his or her signature.